Anti-Human CD39 PE-Cyanine7

Also known as: Ectonucleoside Triphosphate Diphosphohydrolase 1, Entpd1

Clone: eBioA1 (A1)

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 25-0399

Cat. No. Size
25-0399-41 25 tests
25-0399-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD39 PE-Cy7.

Staining of normal human peripheral blood cells with Anti-Human CD19 APC (cat. 17-0199) and Mouse...View More

  • Data for Anti-Human CD39 PE-Cy7.
Description

Description: The eBioA1 monoclonal antibody reacts with human CD39 also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1) or NTPDase. CD39 is an integral membrane protein with two transmembrane domains and exists as a homotetramer. It is the most prominent ectoenzyme of the immune system. The function of CD39 is to effectively remove toxic extracellular ATP by converting it to ADP or AMP. CD39 is thought to work together with CD73 to hydrolyze ATP and has been well characterized on Langerhans cells. Expression of CD39 was originally identified on activated lymphocytes. Expression is also found on a subset of T cells, B cells and dendritic cells as well as weak staining on monocytes and granulocytes.

Recently, CD39 and CD73 have been found on regulatory T cells (Treg). Expression of CD39 on Treg may facilitate their entry into inflamed areas where high levels of ATP are present. Expression of CD39 on Foxp3+CD4+ cells ranges from 25-45%.

Details
Host Mouse
Isotype IgG1
Reactivity Human
Conjugate PE-Cyanine7
Laser Blue Laser, Green Laser, Yellow-Green Laser
Emit 775 nm
Excite 488 - 561 nm
Legal FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT # 5,268,486, 5,569,587 AND 5,627,027 AND FOREIGN EQUIVALENTS AND PENDING APPLICATIONS. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. sale, lease, license or other transfer of the material or any material derived or produced from it; 2. sale, lease, license or other grant of rights to use this Material or any material derived or produced from it; 3. use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO EBIOSCIENCE, INC. 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA 92121 USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
17-0399 Anti-Human CD39 APC 633 - 647 nm 660 nm FC RUO
14-0399 Anti-Human CD39 Purified FC, IHC RUO
11-0399 Anti-Human CD39 FITC 488 nm 518 nm FC RUO
12-0399 Anti-Human CD39 PE 488 - 561 nm 575 nm FC RUO
46-0399 Anti-Human CD39 PerCP-eFluor® 710 488 nm 710 nm FC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
17-0199 Anti-Human CD19 APC 633 - 647 nm 660 nm FC RUO
25-4714 Mouse IgG1 K Isotype Control PE-Cyanine7 488 - 561 nm 775 nm FC RUO
References

References: Lyck L, Dalmau I, et al. 2008. Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex. J Histochem Cytochem. 56(3):201-21. (A1, IHC frozen, PubMed)

Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell'acqua ML, Rossini PM, Battistini L, Rotzschke O, Falk K. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110(4):1225-32.

Stockl J., O. Majdic, G. Fischer, D. Maurer, W. Knapp. 2001. Monomorphic Molecules Function as Additional Recognition Structures on Haptenated Target Cells for HLA-A1-Restricted, Hapten-Specific CTL. J. Immunol. 167L:2724-2733

Aversa GG., J.A. Waugh, G.A. Bishop, B.M. Hall. 1989. Use of Monoclonal Antibodies to Study in vivo and in vitro-activated Lymphocytes. Transplant Proc. 21(1):349-50.

Aversa GG., M.G. Suranyi, J.A. Waugh, A.G. Bishop, B.M. Hall. 1988. Detection of a Late Lymphocyte Activation Marker by A1, a New Monoclonal Antibody. Transplant Proc. 20(1):49-52.


View More Products

AntigensArea of BiologyCell TypeFormats